The global bisphosphonate drug market is anticipated to grow at a CAGR of nearly 4.5% during the forecast period (2022-2028). Bisphosphonates belong to the class of drugs that prevent the bone mineralization or resorption by stopping the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect […]
